FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← ANTX · AN2 Therapeutics, Inc.
424B5The Raise

AN2 Therapeutics, Inc. files 424B5

Filed Apr 20, 2026 · 2mo ago · Accession 0001193125-26-164095

Plain English

424B5 filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
AN2 Therapeutics, Inc.
Ticker
ANTX
CIK
1880438
Form type
424B5
Filing date
Apr 20, 2026
Report date
—
Document
d802804d424b5.htm
Size
477 KB

More from ANTX

8-KShareholder VoteJun 9, 20268-KReg FD Disclosure · Company UpdateJun 4, 202610-QThe RecordMay 11, 20268-KResults of OperationsMay 11, 2026DEF 14AThe BallotApr 22, 2026DEFA14AThe BallotApr 22, 2026